www.fdanews.com/articles/177551-tela-bio-launches-ovitex-portfolio
TELA Bio has launched its OviTex portfolio, a suite of products intended for ventral hernia repair and abdominal wall reconstruction.
The portfolio consists of six products with a range of sizes, thicknesses and degrees of reinforcement. — Anisa Jibrell